Amorepacific Corp. (New) (090430) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Amorepacific Corp. (New) (090430) has a cash flow conversion efficiency ratio of 0.026x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩143.19 Billion ≈ $97.04 Million USD) by net assets (₩5.53 Trillion ≈ $3.74 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Amorepacific Corp. (New) (090430) market capitalisation for the company's overall valuation and market capitalisation.
Amorepacific Corp. (New) - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Amorepacific Corp. (New)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Amorepacific Corp. (New) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Amorepacific Corp. (New) ranked by their cash flow conversion efficiency. Explore earnings quality score of Amorepacific Corp. (New) to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
H&R Block Inc
NYSE:HRB
|
0.648x |
|
ITEQ Corp
TW:6213
|
-0.026x |
|
Do-Fluoride Chemicals Co Ltd
SHE:002407
|
0.026x |
|
Huaan Securities Co Ltd
SHG:600909
|
0.122x |
|
Planet Labs PBC
NYSE:PL
|
0.035x |
|
Dianthus Therapeutics Inc.
NASDAQ:DNTH
|
-0.042x |
|
NEXTDC Ltd
AU:NXT
|
0.009x |
|
Bezeq Israeli Telecommunication Corp Ltd
TA:BEZQ
|
0.313x |
Annual Cash Flow Conversion Efficiency for Amorepacific Corp. (New) (2007–2025)
The table below shows the annual cash flow conversion efficiency of Amorepacific Corp. (New) from 2007 to 2025. View today's stock price for Amorepacific Corp. (New) for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩5.50 Trillion ≈ $3.73 Billion |
₩583.84 Billion ≈ $395.66 Million |
0.106x | +68.91% |
| 2024-12-31 | ₩5.33 Trillion ≈ $3.61 Billion |
₩334.51 Billion ≈ $226.69 Million |
0.063x | -12.71% |
| 2023-12-31 | ₩4.84 Trillion ≈ $3.28 Billion |
₩348.23 Billion ≈ $235.99 Million |
0.072x | +127.70% |
| 2022-12-31 | ₩4.78 Trillion ≈ $3.24 Billion |
₩151.02 Billion ≈ $102.35 Million |
0.032x | -78.32% |
| 2021-12-31 | ₩4.74 Trillion ≈ $3.22 Billion |
₩691.43 Billion ≈ $468.58 Million |
0.146x | +17.37% |
| 2020-12-31 | ₩4.46 Trillion ≈ $3.03 Billion |
₩554.36 Billion ≈ $375.68 Million |
0.124x | -22.23% |
| 2019-12-31 | ₩4.50 Trillion ≈ $3.05 Billion |
₩718.30 Billion ≈ $486.78 Million |
0.160x | +9.78% |
| 2018-12-31 | ₩4.45 Trillion ≈ $3.01 Billion |
₩646.68 Billion ≈ $438.24 Million |
0.145x | +18.47% |
| 2017-12-31 | ₩4.18 Trillion ≈ $2.83 Billion |
₩512.56 Billion ≈ $347.36 Million |
0.123x | -29.34% |
| 2016-12-31 | ₩3.90 Trillion ≈ $2.64 Billion |
₩676.95 Billion ≈ $458.76 Million |
0.174x | -6.64% |
| 2015-12-31 | ₩3.37 Trillion ≈ $2.29 Billion |
₩627.50 Billion ≈ $425.25 Million |
0.186x | -8.62% |
| 2014-12-31 | ₩2.88 Trillion ≈ $1.95 Billion |
₩586.11 Billion ≈ $397.20 Million |
0.204x | +22.57% |
| 2013-12-31 | ₩2.57 Trillion ≈ $1.74 Billion |
₩426.66 Billion ≈ $289.14 Million |
0.166x | +41.30% |
| 2012-12-31 | ₩2.34 Trillion ≈ $1.59 Billion |
₩275.58 Billion ≈ $186.76 Million |
0.118x | -37.62% |
| 2011-12-31 | ₩2.14 Trillion ≈ $1.45 Billion |
₩403.01 Billion ≈ $273.12 Million |
0.188x | -19.34% |
| 2010-12-31 | ₩1.56 Trillion ≈ $1.06 Billion |
₩364.06 Billion ≈ $246.72 Million |
0.234x | -15.07% |
| 2009-12-31 | ₩1.30 Trillion ≈ $880.80 Million |
₩357.58 Billion ≈ $242.33 Million |
0.275x | +33.80% |
| 2008-12-31 | ₩1.12 Trillion ≈ $755.83 Million |
₩229.34 Billion ≈ $155.42 Million |
0.206x | -13.21% |
| 2007-12-31 | ₩953.28 Billion ≈ $646.02 Million |
₩225.86 Billion ≈ $153.06 Million |
0.237x | -- |
About Amorepacific Corp. (New)
Amorepacific Corporation researches, develops, manufactures, markets, sells, and trades cosmetics and beauty products worldwide. It offers cosmetics under the Sulwhasoo, Laneige, Innisfree, AP Beauty, Hera, Primera, Iope, Mamonde, Hanyul, espoir, Etude, Odyssey, Be Ready, Holitual, Tata Harper, and Cosrx brands; medical beauty products under the Aestura brand; beauty devices under the maekON bran… Read more